← FDA DRUG APPROVALS
FDA ANDA · ANDA210639
BETAMETHASONE VALERATE
betamethasone valerate foam
Sponsor: XIROMED
APPLICATION
ANDA210639
TYPE
ANDA
ORIGINAL APPROVAL
2023-04-18
LATEST ACTION
2023-04-18
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Prescription
Products
BETAMETHASONE VALERATEPrescription
BETAMETHASONE VALERATE 0.12% · AEROSOL, FOAM · TOPICAL
Approval history
2023-04-18UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.